We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+1.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.61B
AUM Growth
+$36.4M
Cap. Flow
+$97.7M
Cap. Flow %
6.05%
Top 10 Hldgs %
61.46%
Holding
387
New
81
Increased
131
Reduced
147
Closed
19

Top Buys

Rank Stock Value
1
ASX icon
ASE Group
ASX
+$22.6M
2
MSFT icon
Microsoft
MSFT
+$12.4M
3
AAPL icon
Apple
AAPL
+$9.73M
4
NVDA icon
NVIDIA
NVDA
+$9.56M
5
AMZN icon
Amazon
AMZN
+$6.91M

Top Sells

Rank Stock Value
1
SE icon
Sea Limited
SE
+$20.8M
2
AMD icon
Advanced Micro Devices
AMD
+$16.3M
3
TSM icon
TSMC
TSM
+$7.3M
4
PDD icon
Pinduoduo
PDD
+$2.71M
5
WB icon
Weibo
WB
+$2.43M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 40.2%
2 Technology 29.79%
3 Communication Services 9.9%
4 Healthcare 5.71%
5 Real Estate 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CI icon
251
Cigna
CI
$73.7B
$348K 0.02%
959
+6
+0.6% +$1.98K
SAGE
252
DELISTED
Sage Therapeutics
SAGE
$348K 0.02%
18,544
+2,062
+13% +$47.6K
EA
253
DELISTED
Electronic Arts
EA
$345K 0.02%
2,604
-43
-2% -$5.9K
BMY icon
254
Bristol-Myers Squibb
BMY
$136B
$344K 0.02%
6,350
+731
+13% +$37.2K
ACAD icon
255
Acadia Pharmaceuticals
ACAD
$5.02B
$342K 0.02%
18,488
-4,405
-19% -$109K
CVS icon
256
CVS Health
CVS
$119B
$339K 0.02%
4,255
+597
+16% +$45.6K
VRDN icon
257
Viridian Therapeutics
VRDN
$2.61B
$338K 0.02%
19,323
+8,448
+78% +$164K
BMEA icon
258
Biomea Fusion
BMEA
$125M
$338K 0.02%
+22,605
New +$372K
INBX
259
DELISTED
Inhibrx, Inc. Common Stock
INBX
$334K 0.02%
9,544
+4,032
+73% +$147K
VRSK icon
260
Verisk Analytics
VRSK
$25B
$333K 0.02%
1,413
-31
-2% -$7.45K
IBRX icon
261
ImmunityBio
IBRX
$8.53B
$333K 0.02%
61,922
+22,428
+57% +$102K
BKR icon
262
Baker Hughes
BKR
$62B
$331K 0.02%
9,886
-133
-1% -$4.1K
BSX icon
263
Boston Scientific
BSX
$67.9B
$330K 0.02%
4,823
+216
+5% +$13.9K
AZN icon
264
AstraZeneca
AZN
$252B
$330K 0.02%
2,436
-70
-3% -$9.27K
PTGX icon
265
Protagonist Therapeutics
PTGX
$9.34B
$327K 0.02%
11,304
+2,347
+26% +$63.9K
TTD icon
266
Trade Desk
TTD
$6.38B
$325K 0.02%
3,723
-118
-3% -$8.94K
VCYT icon
267
Veracyte
VCYT
$3.48B
$323K 0.02%
14,581
+6,016
+70% +$147K
CCCC icon
268
C4 Therapeutics
CCCC
$474M
$322K 0.02%
+39,396
New +$305K
MIRM icon
269
Mirum Pharmaceuticals
MIRM
$5.94B
$316K 0.02%
12,583
+5,582
+80% +$153K
KURA icon
270
Kura Oncology
KURA
$1.13B
$314K 0.02%
+14,710
New +$286K
AGIO icon
271
Agios Pharmaceuticals
AGIO
$1.99B
$306K 0.02%
+10,453
New +$280K
RCUS icon
272
Arcus Biosciences
RCUS
$3.72B
$303K 0.02%
16,052
+2,551
+19% +$44.1K
IRON icon
273
Disc Medicine
IRON
$3.07B
$303K 0.02%
+4,861
New +$315K
XEL icon
274
Xcel Energy
XEL
$47.8B
$294K 0.02%
5,479
-15
-0.3% -$857
BDX icon
275
Becton Dickinson
BDX
$51.6B
$291K 0.02%
1,177
+163
+16% +$39K
9 10
11
12 13

Similar funds

ACM
Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $4.47B AUM 4.2% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
BP
BC Partners New York $4.43B AUM 49.12% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
AOI
Auto-Owners Insurance Lansing, Michigan $4.43B AUM 30.05% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

E Fund Management's Q1 2024 Portfolio in Review

As of Q1 2024, E Fund Management held 387 positions worth $1.61B, up 2.3% from $1.58B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

E Fund Management deployed $97.7M of net new capital in Q1 2024, opening 81 new positions and adding to 131 existing holdings. Its largest new stake was ASE Group: 2,300,000 shares worth $25.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 40% of assets, down from 50% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Sea Limited, an estimated $20.8M trimmed.

  • E Fund Management's largest Q1 2024 buy was ASE Group: 2,300,000 shares worth $25.3M.
  • E Fund Management added most to Microsoft in Q1 2024, an estimated $12.4M increase.
  • E Fund Management's biggest Q1 2024 reduction was Sea Limited, cutting an estimated $20.8M.
  • E Fund Management fully exited Hesai Group in Q1 2024, selling an estimated $1.52M.
  • E Fund Management's ten largest holdings make up 61% of its $1.61B portfolio in Q1 2024.
  • E Fund Management opened 81 new positions and closed 19 in Q1 2024.
  • E Fund Management's portfolio value rose 2.3% quarter-over-quarter to $1.61B.

Based on E Fund Management's 13F filing for Q1 2024, filed 13 May 2024.